NCT07471191

Brief Summary

Primary Objective: Compare 6-month graft success rates between 0.5 mm sliced and 1.8 mm full-thickness tragal cartilage grafts.(3) H1: Sliced cartilage yields ≥90% success versus ≤80% for full-thickness.(3) H0: No difference between arms. Secondary Objectives:

  • PTA-ABG closure at 6/12 months.(4)
  • Speech discrimination score improvement.(4)
  • Operative time.(6)

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
21mo left

Started Apr 2026

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Apr 2026May 2028

First Submitted

Initial submission to the registry

March 10, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 13, 2026

Completed
19 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2028

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

March 10, 2026

Last Update Submit

March 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Outcome of partial-thickness vs full-thickness tragal cartilage grafts in endoscopic type 1 tympanoplasty in adults.

    Outcome of partial-thickness vs full-thickness tragal cartilage grafts in endoscopic type 1 tympanoplasty in adults.

    baseline

Interventions

endoscopeDEVICE

endoscopic type 1 tympano plasty

Also known as: tympanoplasty

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Inclusion (all required): * Age 18-65 years. * safe chronic perforation ≥6 months. * Subtotal (25-75%) or large (\>75%) pars tensa defect. * Dry ear ≥3 months (culture-negative). * Intact ossicles, healthy mucosa. * Viable tragal cartilage. * Informed written consent capability. Exclusion criteria : * unsafe otitis, * active discharge, * Eustachian dysfunction e.g cleft palate, * ossicular defects * prior surgery, * unfit patients * non-compliance

You may qualify if:

  • Age 18-65 years.
  • safe chronic perforation ≥6 months.
  • Subtotal (25-75%) or large (\>75%) pars tensa defect.
  • Dry ear ≥3 months (culture-negative).
  • Intact ossicles, healthy mucosa.
  • Viable tragal cartilage.
  • Informed written consent capability.

You may not qualify if:

  • unsafe otitis,
  • active discharge,
  • Eustachian dysfunction e.g cleft palate,
  • ossicular defects
  • prior surgery,
  • unfit patients
  • non-compliance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.

    PMID: 15273542BACKGROUND
  • Rizer FM. Overlay versus underlay tympanoplasty. Part II: the study. Laryngoscope. 1997 Dec;107(12 Pt 2):26-36. doi: 10.1097/00005537-199712001-00002.

    PMID: 9395344BACKGROUND

MeSH Terms

Interventions

EndoscopesTympanoplasty

Intervention Hierarchy (Ancestors)

Diagnostic EquipmentEquipment and SuppliesSurgical EquipmentOtologic Surgical ProceduresOtorhinolaryngologic Surgical ProceduresSurgical Procedures, Operative

Central Study Contacts

Monica Gamil Tawfiq

CONTACT

Ezzat Mohamed Saleh, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
dr

Study Record Dates

First Submitted

March 10, 2026

First Posted

March 13, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

May 1, 2028

Last Updated

March 13, 2026

Record last verified: 2026-03